Why BioNTech (BNTX) Shares Are Volatile Today - Benzinga

2 days ago · Shares of BioNTech fell 4% on Monday. Vaccine stocks are volatile after Moderna's updated revenue guidance for 2025, which fell below analyst expectations.

4%
OFF

Why BioNTech (BNTX) Shares Are Volatile Today - Benzinga

2 weeks from now

2 days ago · Shares of BioNTech fell 4% on Monday. Vaccine stocks are volatile after Moderna's updated revenue guidance for 2025, which fell below analyst expectations.

benzinga.com

€1.06
OFF

Why BioNTech (BNTX) Shares Are Trading Lower Today - Benzinga

2 weeks from now

Aug 7, 2023 · After the end of the reporting period, the payment settling BioNTech's gross profit share for Q1 of 2023 (as defined by the contract with Pfizer) in the amount of €1.06 billion was …

benzinga.com

4%
OFF

Why BioNTech (BNTX) Shares Are Volatile Today

2 weeks from now

2 days ago · Shares of BioNTech fell 4% on Monday. Vaccine stocks are volatile after Moderna's updated revenue guidance for 2025, which fell below analyst expectations.

sahmcapital.com

5%
OFF

Why BioNTech, Moderna, And Novavax Stocks Are Sliding Today

2 weeks from now

Sep 27, 2021 · What happened Shares of several COVID-19 vaccine makers were sliding on Monday. BioNTech stock (NASDAQ: BNTX) was down 6.5% at 12:09 p.m. EDT. Shares of …

nasdaq.com

67%
OFF

What's Going On With BioNTech (BNTX) Shares? - TradingView

2 weeks from now

Aug 1, 2024 · BioNTech SE – ADR BNTX shares are trading lower by 5.67% to $81.32 during Thursday’s session. Shares of various vaccine manufacturers are declining after Moderna Inc …

tradingview.com

110%
OFF

Why BioNTech Stock Is Sinking Today - Nasdaq

2 weeks from now

May 4, 2021 · It's important to remember that even after factoring in BioNTech's Tuesday morning decline, it's still up by more than 110% year to date. Some volatility is to be expected with high …

nasdaq.com

$142.72
OFF

BioNTech (BNTX) Stock Forecast And Price Target 2025

2 weeks from now

5 days ago · BNTX's current price target is $142.72. Learn why top analysts are making this stock forecast for BioNTech at MarketBeat.

marketbeat.com

4%
OFF

BioNTech (NASDAQ:BNTX) Stock Quotes, Forecast And News …

2 weeks from now

1 day ago · Shares of BioNTech fell 4% on Monday. Vaccine stocks are volatile after Moderna's updated revenue guidance for 2025, which fell below analyst expectations.

benzinga.com

40%
OFF

Truist Rates BioNTech A Buy, Citing 40% Upside Potential With Key …

2 weeks from now

5 days ago · On Friday, Truist Securities began coverage on BioNTech shares (NASDAQ: BNTX) with a Buy rating, accompanied by a price target set at $172.00. The securities firm's analysis …

investing.com

42%
OFF

Why Shares Of BioNTech Were Falling Today - The Motley Fool

2 weeks from now

Aug 10, 2021 · What happened Shares of BioNTech (BNTX -7.42%) were down nearly 7% today after two studies of more than 50,000 patients in the Mayo Clinic Health System showed rival …

fool.com

85%
OFF

Why BioNTech Shares Are Trading Lower Again Today - Benzinga

2 weeks from now

Oct 4, 2021 · BNTX Price Action: BioNTech has traded as high as $464 and as low as $69.31 over a 52-week period. The stock was down 4.85% at $242.69 at time of publication. Photo: …

benzinga.com

25%
OFF

Why BioNTech Shares Are Rising During Monday's Session

2 weeks from now

Aug 28, 2023 · BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by some 2.25% to $120.26 Monday. The stock is gaining today amid rising COVID-19 cases in the U.S.

benzinga.com

FAQs about Why BioNTech (BNTX) Shares Are Volatile Today - Benzinga Coupon?

Why are biontech se (bntx) shares falling?

BioNTech SE (NASDAQ: BNTX) shares are falling in the premarket session today after the company reported Q4 earnings and expected lower annual revenue from the Covid-19 vaccine. BioNTech reported Q4 FY22 revenues of €4.28 billion, down from €5.5 billion a year ago, due to the changes in the demand for COVID-19 vaccines. ...

Should you buy biontech (bntx)?

Out of the 14 analysts, 5 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for BNTX. According to the 14 analysts' twelve-month price targets for BioNTech, the average price target is $135.54. The highest price target for BNTX is $171.00, while the lowest price target for BNTX is $100.00. ...

What is the average price target for biontech (bntx)?

According to the 14 analysts' twelve-month price targets for BioNTech, the average price target is $135.54. The highest price target for BNTX is $171.00, while the lowest price target for BNTX is $100.00. The average price target represents a forecasted upside of 22.24% from the current price of $110.88. ...

Why did BioNTech's stock drop by 7% today?

Shares of BioNTech (BNTX) were down nearly 7% today. Two studies of more than 50,000 patients in the Mayo Clinic Health System showed rival Moderna's vaccine might be more effective against the delta variant of the SARS-CoV-2 coronavirus. ...

Will biontech SE meet market expectations?

BioNTech SE's recent earnings per share (EPS) results have fallen short of consensus estimates, raising concerns about its ability to meet market expectations. The company's revenue for the quarter was down 23.3% year-over-year, reflecting a decline in sales that may affect future profitability and investor confidence. ...

What is the price target for bntx (bntx)?

The highest price target for BNTX is $171.00, while the lowest price target for BNTX is $100.00. The average price target represents a forecasted upside of 22.24% from the current price of $110.88. Enter your email address to receive the latest news and analysts' ratings for BioNTech and its competitors. Election warning coming true… (Ad) ...